|
US4670447A
(en)
|
1983-08-22 |
1987-06-02 |
Hoechst-Roussel Pharmaceuticals Inc. |
Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
|
|
GB8607294D0
(en)
|
1985-04-17 |
1986-04-30 |
Ici America Inc |
Heterocyclic amide derivatives
|
|
PT95899A
(pt)
|
1989-11-17 |
1991-09-13 |
Glaxo Group Ltd |
Processo para a preparacao de derivados indole
|
|
TW263508B
(cg-RX-API-DMAC7.html)
|
1991-02-12 |
1995-11-21 |
Pfizer |
|
|
JP3414433B2
(ja)
|
1993-03-01 |
2003-06-09 |
日本化薬株式会社 |
電子写真用トナー
|
|
US5639780A
(en)
|
1995-05-22 |
1997-06-17 |
Merck Frosst Canada, Inc. |
N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
|
|
DE19523446A1
(de)
|
1995-06-28 |
1997-01-02 |
Bayer Ag |
Benzotriazole
|
|
AU6490396A
(en)
|
1995-07-14 |
1997-02-18 |
Smithkline Beecham Corporation |
Substituted-pent-4-ynoic acids
|
|
JPH11514969A
(ja)
|
1995-08-10 |
1999-12-21 |
バイエル・アクチエンゲゼルシヤフト |
ハロベンゾイミダゾール類および殺微生物剤としてのそれらの使用
|
|
EP0882718B1
(en)
|
1995-12-28 |
2005-08-31 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
|
CA2258728C
(en)
|
1996-06-19 |
2011-09-27 |
Rhone Poulenc Rorer Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
|
HUP9903330A2
(hu)
|
1996-11-19 |
2000-03-28 |
Amgen Inc. |
Gyulladásgátló hatású, aril- és heteroaril csoporttal szubsztituált kondenzált pirrolszármazékok, valamint ezeket tartalmazó gyógyászati készítmények
|
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
US6133290A
(en)
|
1998-07-31 |
2000-10-17 |
Eli Lilly And Company |
5-HT1F agonists
|
|
CZ2001959A3
(cs)
|
1998-09-18 |
2001-12-12 |
Basf Aktiengesellschaft |
4-Aminopyrrolopyrimidiny jako inhibitory kinasy
|
|
US6348032B1
(en)
|
1998-11-23 |
2002-02-19 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with benzimidazole derivatives
|
|
WO2001012600A1
(en)
|
1999-08-12 |
2001-02-22 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
US7115750B1
(en)
|
1999-09-20 |
2006-10-03 |
Takeda Pharmaceutical Company Limited |
Melanin concentrating hormone antagonist
|
|
GB0117577D0
(en)
|
2001-02-16 |
2001-09-12 |
Aventis Pharm Prod Inc |
Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
|
|
TWI239942B
(en)
|
2001-06-11 |
2005-09-21 |
Dainippon Pharmaceutical Co |
N-arylphenylacetamide derivative and pharmaceutical composition containing the same
|
|
MXPA04001014A
(es)
|
2001-08-03 |
2004-05-27 |
Schering Corp |
Novedosos inhibidores de la gama secretasa.
|
|
US7355042B2
(en)
|
2001-10-16 |
2008-04-08 |
Hypnion, Inc. |
Treatment of CNS disorders using CNS target modulators
|
|
DE10229777A1
(de)
|
2002-07-03 |
2004-01-29 |
Bayer Ag |
Indolin-Phenylsulfonamid-Derivate
|
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
|
JP4601038B2
(ja)
|
2003-03-26 |
2010-12-22 |
第一三共株式会社 |
インドリルマレイミド類
|
|
SG146683A1
(en)
*
|
2003-09-17 |
2008-10-30 |
Janssen Pharmaceutica Nv |
Fused heterocyclic compounds as serotonin receptor modulators
|
|
NZ546611A
(en)
|
2003-09-18 |
2010-02-26 |
Conforma Therapeutics Corp |
Novel heterocyclic compounds as HSP90-inhibitors
|
|
SE0302760D0
(sv)
|
2003-10-20 |
2003-10-20 |
Biovitrum Ab |
New compounds
|
|
US7420059B2
(en)
|
2003-11-20 |
2008-09-02 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
JP2007517052A
(ja)
|
2003-12-23 |
2007-06-28 |
ノバルティス アクチエンゲゼルシャフト |
二環式ヘテロ環式p−38キナーゼ阻害剤
|
|
EP1771204A4
(en)
|
2004-07-01 |
2008-08-13 |
Univ New York |
COMPOSITIONS AND METHOD FOR MODULATING ROR-GAMMA-T
|
|
GT200500208A
(es)
|
2004-08-03 |
2006-03-02 |
|
Indazoles ùtiles para tratar enfermedades cardiovasculares
|
|
US20070010537A1
(en)
|
2004-08-20 |
2007-01-11 |
Kazumasa Hamamura |
Fused pyramidine derivative and use thereof
|
|
CN101048407A
(zh)
|
2004-09-03 |
2007-10-03 |
普莱希科公司 |
双环杂芳基pde4b抑制剂
|
|
SE0402762D0
(sv)
|
2004-11-11 |
2004-11-11 |
Astrazeneca Ab |
Indazole sulphonamide derivatives
|
|
CN100516049C
(zh)
|
2004-11-16 |
2009-07-22 |
永信药品工业股份有限公司 |
抗血管生成药n2-(取代的芳基甲基)-3-(取代的苯基)吲唑的合成
|
|
AR051780A1
(es)
|
2004-11-29 |
2007-02-07 |
Japan Tobacco Inc |
Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
|
|
EP1828180A4
(en)
|
2004-12-08 |
2010-09-15 |
Glaxosmithkline Llc |
1H-pyrrolo [2,3-BETA] PYRIDINE
|
|
RU2008110908A
(ru)
|
2005-08-25 |
2009-09-27 |
Шеринг Корпорейшн (US) |
Производные имидазола в качестве функционально селективных агонистов альфа2с адренорецепторов
|
|
US8003624B2
(en)
|
2005-08-25 |
2011-08-23 |
Schering Corporation |
Functionally selective ALPHA2C adrenoreceptor agonists
|
|
JP2009509928A
(ja)
|
2005-09-01 |
2009-03-12 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
カリウムチャンネル開口剤としての新規ベンゾピラン誘導体
|
|
JP4843040B2
(ja)
|
2005-09-15 |
2011-12-21 |
エフ.ホフマン−ラ ロシュ アーゲー |
肝カルニチンパルミトイルトランスフェラーゼのインヒビターとして有用な新規ヘテロ二環式誘導体
|
|
AU2007214594B2
(en)
|
2006-02-13 |
2010-11-11 |
F. Hoffmann-La Roche Ag |
Heterobicyclic sulfonamide derivatives for the treatment of diabetes
|
|
KR101411695B1
(ko)
|
2006-02-17 |
2014-07-03 |
리겔 파마슈티칼스, 인크. |
자가면역 질환의 치료 또는 예방을 위한 2,4-피리미딘디아민 화합물
|
|
EP1984351A1
(en)
|
2006-02-17 |
2008-10-29 |
Memory Pharmaceuticals Corporation |
Compounds having 5-ht6 receptor affinity
|
|
JP4675801B2
(ja)
|
2006-03-06 |
2011-04-27 |
日本メナード化粧品株式会社 |
Ror活性化剤
|
|
US7723330B2
(en)
|
2006-03-07 |
2010-05-25 |
Array Biopharma Inc. |
Heterobicyclic pyrazole compounds and methods of use
|
|
WO2007125405A2
(en)
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
|
US20080305169A1
(en)
|
2006-05-26 |
2008-12-11 |
Japan Tobacco Inc. |
Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
|
|
EP2029550A2
(en)
|
2006-06-01 |
2009-03-04 |
Wyeth a Corporation of the State of Delaware |
1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands
|
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2008003703A1
(en)
|
2006-07-03 |
2008-01-10 |
Biovitrum Ab (Publ) |
Indoles as 5-ht6 modulators
|
|
TWI315304B
(en)
|
2006-08-31 |
2009-10-01 |
Univ Taipei Medical |
Indoline-sulfonamides compounds
|
|
WO2008045664A2
(en)
|
2006-10-06 |
2008-04-17 |
Kalypsys, Inc. |
Heterocyclic pde4 inhibitors as antiinflammatory agents
|
|
WO2008062740A1
(fr)
|
2006-11-20 |
2008-05-29 |
Japan Tobacco Inc. |
Composé azoté à anneaux fusionnés et son utilisation
|
|
US7799933B2
(en)
|
2006-12-21 |
2010-09-21 |
Hoffman-La Roche Inc. |
Sulfonamide derivatives
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
MX2009011210A
(es)
|
2007-04-16 |
2009-10-30 |
Abbott Lab |
Inhibidores de mcl1 de indol 7-no sustituido.
|
|
GB0708141D0
(en)
|
2007-04-26 |
2007-06-06 |
Syngenta Participations Ag |
Improvements in or relating to organic compounds
|
|
AR067326A1
(es)
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
EP2154965A4
(en)
|
2007-05-29 |
2011-08-17 |
Glaxosmithkline Llc |
NAPHTHYRIDINE DERIVATIVES AS P13 KINASE INHIBITORS
|
|
AR068046A1
(es)
|
2007-06-05 |
2009-11-04 |
Schering Corp |
Derivados policiclicos de indazol y su uso como inhibidores de erk para el tratamiento del cancer
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
JP2010534665A
(ja)
|
2007-07-25 |
2010-11-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルココルチコイドミメチックス、それらの製造方法、医薬組成物、及びこれらの使用
|
|
EP2197876A1
(en)
|
2007-08-29 |
2010-06-23 |
Glaxosmithkline LLC |
Thiazole and oxazole kinase inhibitors
|
|
US7960376B2
(en)
|
2007-09-14 |
2011-06-14 |
Cara Therapeutics, Inc. |
Benzo-fused heterocycles
|
|
RU2364597C1
(ru)
|
2007-12-14 |
2009-08-20 |
Андрей Александрович Иващенко |
ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
|
|
US7960377B2
(en)
|
2008-03-28 |
2011-06-14 |
Cara Therapeutics, Inc. |
Substituted pyridoxazines
|
|
EP2280946B1
(en)
|
2008-06-05 |
2016-02-10 |
Glaxo Group Limited |
4-carboxamide indazole derivatives useful as inhibitors of p13-kinases
|
|
WO2009147190A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Novel compounds
|
|
WO2009147188A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Benzpyrazol derivatives as inhibitors of pi3 kinases
|
|
NZ589694A
(en)
|
2008-06-09 |
2012-05-25 |
Sanofi Aventis |
Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
|
|
WO2009149819A1
(en)
|
2008-06-09 |
2009-12-17 |
Sanofi-Aventis |
Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
|
|
EP2298731A4
(en)
|
2008-06-25 |
2011-09-21 |
Takeda Pharmaceutical |
AMIDE COMPOUND
|
|
WO2010017827A1
(en)
|
2008-08-14 |
2010-02-18 |
European Molecular Biology Laboratory |
6-substituted 1-sulfonyl-2, 3-dihydro-indole derivatives for the treatment of proliferative diseases
|
|
SI2344471T1
(sl)
|
2008-10-02 |
2013-11-29 |
Taisho Pharmaceutical Co., Ltd. |
Derivat 7-piperidinoalkil-3,4-dihidrokvinolona
|
|
EP2181710A1
(en)
|
2008-10-28 |
2010-05-05 |
Phenex Pharmaceuticals AG |
Ligands for modulation of orphan receptor-gamma (NR1F3) activity
|
|
WO2010050837A1
(ru)
|
2008-10-28 |
2010-05-06 |
Haskin Lev Yakovlevich |
Ветроэнергетическая установка
|
|
WO2010057101A2
(en)
|
2008-11-17 |
2010-05-20 |
Schering Corporation |
Compounds useful as hiv blockers
|
|
EP2367598B1
(en)
|
2008-11-19 |
2014-04-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of diacylglycerol acyltransferase
|
|
CN102264743B
(zh)
|
2008-11-25 |
2015-02-11 |
罗彻斯特大学 |
Mlk抑制剂及其使用方法
|
|
CN102388054B
(zh)
|
2008-12-19 |
2015-03-04 |
西特里斯药业公司 |
噻唑并吡啶沉默调节蛋白调节剂的化合物
|
|
TW201030007A
(en)
|
2009-02-06 |
2010-08-16 |
Gruenenthal Gmbh |
Substituted spiro-amides as b1r modulators
|
|
US8524751B2
(en)
|
2009-03-09 |
2013-09-03 |
GlaxoSmithKline Intellecutual Property Development |
4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
|
|
TW201102391A
(en)
|
2009-03-31 |
2011-01-16 |
Biogen Idec Inc |
Certain substituted pyrimidines, pharmaceutical compositions thereof, and methods for their use
|
|
WO2010123139A1
(ja)
|
2009-04-24 |
2010-10-28 |
持田製薬株式会社 |
スルファモイル基を有するアリールカルボキサミド誘導体
|
|
RS53830B1
(sr)
|
2009-04-30 |
2015-06-30 |
Glaxo Group Limited |
Indazoli supstituisani oksazolom kao inhibitori pi3-kinaze
|
|
WO2010150837A1
(ja)
|
2009-06-25 |
2010-12-29 |
第一三共株式会社 |
インドリン誘導体
|
|
EP2459184A1
(en)
|
2009-07-31 |
2012-06-06 |
The Brigham and Women's Hospital, Inc. |
Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
|
|
US8119683B2
(en)
|
2009-08-10 |
2012-02-21 |
Taipei Medical University |
Aryl substituted sulfonamide compounds and their use as anticancer agents
|
|
WO2011059839A1
(en)
|
2009-10-29 |
2011-05-19 |
Sirtris Pharmaceuticals, Inc. |
Bicyclic pyridines and analogs as sirtuin modulators
|
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
|
EP2507231A1
(en)
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
|
WO2011067365A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of p13 kinases
|
|
AU2010330894A1
(en)
|
2009-12-18 |
2012-07-05 |
Janssen Pharmaceutica Nv |
Substituted aminothiazolone indazoles as estrogen related receptor-aalpha modulators
|
|
US9260382B2
(en)
|
2010-02-16 |
2016-02-16 |
Uwm Research Foundation |
Methods of reducing virulence in bacteria
|
|
CA2791738C
(en)
|
2010-03-01 |
2020-06-09 |
Gtx, Inc. |
Aryl imidazolyl compounds for the treatment of cancer
|
|
EP2571361A4
(en)
|
2010-05-19 |
2013-11-13 |
Univ North Carolina |
PYRAZOLOPYRIMIDINE COMPOUNDS FOR CANCER TREATMENT
|
|
EP2613781B1
(en)
|
2010-09-08 |
2016-08-24 |
GlaxoSmithKline Intellectual Property Development Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
|
HRP20151017T1
(hr)
|
2010-09-08 |
2015-10-23 |
Glaxosmithkline Intellectual Property Development Limited |
Polimorfi i soli n-[5-[4-(5-{[(2r,6s)-2,6-dimetil-4-morfolinil]metil}-1,3-oksazol-2-il)-1h-indazol-6-il]-2-(metiloksi)-3-piridinil]metansulfonamida
|
|
WO2012037108A1
(en)
|
2010-09-13 |
2012-03-22 |
Glaxosmithkline Llc |
Aminoquinoline derivatives as antiviral agents
|
|
JP6063870B2
(ja)
|
2010-11-08 |
2017-01-18 |
ライセラ・コーポレイション |
RORγ活性の阻害用のN−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療
|
|
KR20120063283A
(ko)
|
2010-12-07 |
2012-06-15 |
제일약품주식회사 |
신규한 피라졸로 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
|
|
WO2012085168A1
(en)
|
2010-12-22 |
2012-06-28 |
Ludwig-Maximilians-Universität München |
Organozinc complexes and processes for making and using the same
|
|
EP2487159A1
(en)
*
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
EP2511263A1
(en)
|
2011-04-14 |
2012-10-17 |
Phenex Pharmaceuticals AG |
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
|
JP2014166961A
(ja)
|
2011-06-20 |
2014-09-11 |
Dainippon Sumitomo Pharma Co Ltd |
新規インダゾール誘導体
|
|
RU2014149136A
(ru)
|
2012-05-08 |
2016-07-10 |
Мерк Шарп И Доум Корп. |
ТЕТРАГИДРОНАФТИРИДИНОВЫЕ И РОДСТВЕННЫЕ БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ ДЛЯ ИНГИБИРОВАНИЯ RORγ АКТИВНОСТИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ
|
|
CA2871504C
(en)
|
2012-05-08 |
2020-07-21 |
Merck Sharp & Dohme Corp. |
Bicyclic sulfone compounds for inhibition of rorgamma activity and the treatment of disease
|
|
WO2014026329A1
(en)
*
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026327A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026330A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
|
|
WO2014026328A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2015008234A1
(en)
*
|
2013-07-17 |
2015-01-22 |
Glenmark Pharmaceuticals S.A. |
Bicyclic heterocyclic compounds as ror gamma modulators
|
|
TW201605797A
(zh)
|
2013-12-10 |
2016-02-16 |
葛蘭馬克製藥公司 |
作為ror伽馬調節物的雙環雜芳基化合物
|
|
WO2015095792A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Carbamate benzoxaxine propionic acids and acid derivatives for modulation of rorgamma activity and the treatment of disease
|
|
WO2015095795A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE, AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
|
|
WO2015095788A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
|
|
WO2015139621A1
(zh)
*
|
2014-03-18 |
2015-09-24 |
北京韩美药品有限公司 |
4-杂芳基取代的苯甲酸或苯甲酰胺类化合物
|
|
JP2016141632A
(ja)
|
2015-01-30 |
2016-08-08 |
第一三共株式会社 |
縮合二環式ヘテロ環誘導体
|
|
CA2975997A1
(en)
|
2015-02-11 |
2016-08-18 |
Merck Sharp & Dohme Corp. |
Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2016128908A1
(en)
*
|
2015-02-12 |
2016-08-18 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|